Status Asthmaticus: Relief Tactics and Drugs

Definition and Assessment

Severity Classification at Presentation

⚠️ Critical sign: A normal or rising PaCO₂ in a tachypneic asthmatic signals impending respiratory failure and need for ventilatory support (Harrison's, p. 7939).

Step-by-Step Management Algorithm

Step 1 — Immediate Stabilization (First 0–20 min)

1. Position: Upright (sitting), supplemental O₂ to maintain SpO₂ ≥ 93–95%
2. IV access + monitoring (ECG, pulse oximetry, ABG if severe)
3. PEFR or FEV₁ measurement (if feasible)
4. Chest X-ray to exclude pneumothorax, pneumonia

Step 2 — First-Line Bronchodilators

Short-Acting β₂-Agonists (SABA) — Cornerstone of acute relief

• Nebulized continuous salbutamol (10–15 mg/hr) is an option in life-threatening status
• MDI + spacer is as effective as nebulizer in moderate attacks when used correctly

Anticholinergics (Ipratropium) — Additive bronchodilation

• Combine with SABA in all moderate-to-severe attacks — reduces hospitalization rate
• Less effective than β₂-agonists alone; do not use as monotherapy

Step 3 — Corticosteroids (Start Early, Within the First Hour)

• Oral and IV are equivalent in bioavailability — use IV only if patient cannot swallow
• Effect onset: 4–6 hours; do not delay other treatments waiting for steroids to work
• Inhaled corticosteroids (ICS) do not replace systemic steroids in acute status

Step 4 — Second-Line / Add-On Agents

Magnesium Sulfate (IV) — For life-threatening or refractory attacks

• Mechanism: Blocks calcium-mediated smooth muscle contraction → bronchodilation
• Dose: 2 g IV over 20 minutes (single dose)
• Indicated when SpO₂ <92% or no response to SABA + steroids after ~1 hour
• Nebulized MgSO₄ (isotonic, 2.5 mL of 250 mmol/L) may add modest benefit

Aminophylline/Theophylline — Falling out of favor

• Dose: Loading 5–6 mg/kg IV over 20–30 min, then 0.5 mg/kg/hr infusion
• Narrow therapeutic window (5–15 µg/mL); risk of arrhythmias, seizures
• Current guidelines recommend only if patient is refractory to all above measures and with careful TDM (therapeutic drug monitoring)
• Do not use in patients already on oral theophylline without checking serum levels

Heliox (Helium-Oxygen 80:20 or 70:30)

• Lower density than air → reduces turbulent flow → improves drug delivery and work of breathing
• Useful as bridge therapy in severe cases while other treatments take effect
• Can be used to drive nebulizers for bronchodilator delivery

Ketamine (IV)

• Dissociative anesthetic with intrinsic bronchodilatory properties
• Dose: 1–2 mg/kg IV for procedural sedation or as pre-intubation agent
• Preferred induction agent if intubation is required

Step 5 — Ventilatory Support

Non-Invasive Ventilation (NIV/BiPAP)

• Consider in patients with PaCO₂ ≥ 45 mmHg or impending respiratory failure
• Not universally accepted in asthma; use with caution; requires cooperative patient

Invasive Mechanical Ventilation (IMV)

• Respiratory or cardiac arrest
• Altered consciousness, exhaustion
• Rising PaCO₂ despite maximal therapy
• SpO₂ <90% refractory to O₂

• Low respiratory rate (10–14/min) and small tidal volumes (6–8 mL/kg)
• Allow prolonged expiration (I:E ratio 1:3 or greater) to prevent air trapping
• Permissive hypercapnia: accept PaCO₂ 45–60+ mmHg to avoid barotrauma
• Correct critical acidosis (pH <7.20) with sodium bicarbonate if needed
• Neuromuscular blockade (e.g., vecuronium, rocuronium) may be necessary in severe cases
• Bronchoscopy to clear mucus plugs — use cautiously given ventilation difficulties

Drugs NOT Recommended in Acute Status Asthmaticus

Monitoring and Disposition

• Reassess PEFR/FEV₁, SpO₂, respiratory rate every 30–60 min
• Discharge criteria: PEFR >60–70% predicted, SpO₂ ≥94% on room air, sustained response ≥60 min after last bronchodilator
• Admit to ICU if: life-threatening features, rising CO₂, poor response after 1–2 hours of maximal ED therapy
• Continue oral prednisolone for 5–7 days post-discharge
• Add/optimize controller therapy (ICS ± LABA) before discharge; review inhaler technique
• Arrange follow-up within 1–2 weeks

Summary Algorithm

Acute severe asthma
        │
        ▼
O₂ → SpO₂ ≥93%
SABA nebulized (salbutamol) every 20 min × 3
+ Ipratropium (combined nebulization)
+ Systemic corticosteroids (oral/IV)
        │
   No improvement
        ▼
IV Magnesium sulfate 2 g over 20 min
Continue SABA (continuous nebulization)
Consider IV salbutamol
        │
   Worsening / CO₂ rising
        ▼
NIV (BiPAP) trial if conscious
Consider heliox, ketamine
        │
   Respiratory failure
        ▼
Intubate — low rate, small Vt, permissive hypercapnia
Neuromuscular blockade if needed